Cite
MLA Citation
Ajit Suri et al.. “Population Pharmacokinetic Modeling and Exposure–Response Assessment for the Antibody‐Drug Conjugate Brentuximab Vedotin in Hodgkin's Lymphoma in the Phase III ECHELON‐1 Study.” Clinical pharmacology & therapeutics, vol. 106, no. 6, 2019, pp. 1268–1279. http://access.bl.uk/ark:/81055/vdc_100095179781.0x00005e